172 related articles for article (PubMed ID: 28702770)
21. The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy.
Barton SR; Smith IE; Kirby AM; Ashley S; Walsh G; Parton M
Eur J Cancer; 2011 Sep; 47(14):2099-106. PubMed ID: 21658935
[TBL] [Abstract][Full Text] [Related]
22. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
23. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery.
Zhang Y; Fukatsu H; Naganawa S; Satake H; Sato Y; Ohiwa M; Endo T; Ichihara S; Ishigaki T
Breast Cancer; 2002; 9(3):231-9. PubMed ID: 12185335
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
25. Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S339-42. PubMed ID: 19777181
[TBL] [Abstract][Full Text] [Related]
26. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis.
Capobianco G; Spaliviero B; Dessole S; Rocca PC; Cherchi PL; Ambrosini G; Meloni F; Meloni GB
Breast J; 2007; 13(3):305-7. PubMed ID: 17461909
[TBL] [Abstract][Full Text] [Related]
27. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger.
Freedman GM; Fowble BL; Hanlon AL; Myint MA; Hoffman JP; Sigurdson ER; Eisenberg BL; Goldstein LJ; Fein DA
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):599-605. PubMed ID: 9635708
[TBL] [Abstract][Full Text] [Related]
28. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.
Guenther JM; Hansen NM; DiFronzo LA; Giuliano AE; Collins JC; Grube BL; O'Connell TX
Arch Surg; 2003 Jan; 138(1):52-6. PubMed ID: 12511150
[TBL] [Abstract][Full Text] [Related]
29. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
30. Outcome after treatment of patients with mammographically occult, magnetic resonance imaging-detected breast cancer presenting with axillary lymphadenopathy.
Chen C; Orel SG; Harris E; Schnall MD; Czerniecki BJ; Solin LJ
Clin Breast Cancer; 2004 Apr; 5(1):72-7. PubMed ID: 15140289
[TBL] [Abstract][Full Text] [Related]
31. Occult breast carcinoma presenting as axillary metastases.
Foroudi F; Tiver KW
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):143-7. PubMed ID: 10758316
[TBL] [Abstract][Full Text] [Related]
32. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma.
Lieberman S; Sella T; Maly B; Sosna J; Uziely B; Sklair-Levy M
Isr Med Assoc J; 2008 Jun; 10(6):448-52. PubMed ID: 18669145
[TBL] [Abstract][Full Text] [Related]
33. MRI in patients with axillary metastases of occult breast carcinoma.
Tilanus-Linthorst MM; Obdeijn AI; Bontenbal M; Oudkerk M
Breast Cancer Res Treat; 1997 Jun; 44(2):179-82. PubMed ID: 9232276
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
36. Axillary nodal metastasis of occult breast primary cancer.
Tamiolakis D; Antoniou C
Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
38. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
[TBL] [Abstract][Full Text] [Related]
39. Breast conservation treatment for patients presenting with axillary lymphadenopathy from presumed primary breast cancer: the role of breast magnetic resonance imaging for staging.
Chen C; Orel SG; Schnall MD; Harris E; Solin LJ
Clin Breast Cancer; 2002 Aug; 3(3):219-22. PubMed ID: 12196282
[TBL] [Abstract][Full Text] [Related]
40. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin.
Ellerbroek N; Holmes F; Singletary E; Evans H; Oswald M; McNeese M
Cancer; 1990 Oct; 66(7):1461-7. PubMed ID: 2207996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
